Threonine

Threonine

SCHEMBL6520767

CC(N)C(=O)O.CC(O)C(N)C(=O)O.NC(CO)C(=O)O.NCC(=O)O.O=C(O)C1CCCN1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC5A2

The experimentally established mechanism targets of Threonine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Threonine SCHEMBL6520771 1.00
Threonine SCHEMBL28072332 0.98
D-Glutamate SCHEMBL27546761 0.94 GRM8 (0.36)
Threonine SCHEMBL8815158 0.93 PRCP (0.32)
Threonine SCHEMBL527858 0.93 PRCP (0.32)
Threonine SCHEMBL527856 0.93 PRCP (0.32)
Threonine SCHEMBL27592182 0.93 PRCP (0.32)
Threonine SCHEMBL27562283 0.93 PRCP (0.32)
D-Glutamate SCHEMBL27454805 0.91 GRM8 (0.34)
Threonine SCHEMBL11969543 0.91 NOS2 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050164969-A1 Method of extending life span MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2005-07-28 US disclosed